Quantcast

Latest emphysema Stories

2008-10-21 09:00:54

Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways Stents for Emphysema (EASE) trial. The trial principal is Dr. Karl Van Gundy aided by investigators Drs. Michael Peterson, Jose Joseph, Timothy Evans and Kathryn Bilello -- all pulmonologists at UCSF Fresno Medical Education Program. The study is a multi-center, international trial that is designed to evaluate the safety and effectiveness of this new and...

2008-10-07 03:00:08

TOKYO and CHIPPENHAM, England, October 7 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) and Vectura Group plc ("Vectura"; LSE: VEC), announce results of two Phase II studies evaluating the efficacy, safety and tolerability of NVA237 presented at the annual congress of the European Respiratory Society (ERS) in Berlin, Germany. The new data show that NVA237 (glycopyrronium bromide), a novel inhaled long-acting muscarinic antagonist (LAMA), provides...

2008-10-01 12:00:06

Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti-inflammatory therapies, announced today that it had been granted a patent in the U.S. for methods to produce certain proteins in yeast. Among the proteins whose production is covered by the patent (United States Patent 7,419,801) is recombinant alpha 1-antitrypsin (rAAT), the protein used in Respriva(TM), the company's lead product. "This patent extends our patent portfolio and strengthens our intellectual...

2008-09-25 21:00:34

Emory University researchers say they are among those participating in a nationwide U.S. study of airway bypass to ease emphysema. The EASE -- Exhale Airway Stents for Emphysema -- trial focuses on using a new minimally invasive procedure to make new pathways -- kept open by drug-eluting stents to allow trapped air to exit the lungs, says Emory's study leader Dr. Rabih Bechara. "By creating new pathways for airflow with the airway bypass procedure, we hope to reduce hyperinflation and...

2008-09-25 09:00:54

Researchers at Sentara Cardiovascular Research Institute begin a new international study to explore the safety and effectiveness of stents to open airways of patients with advanced emphysema or Chronic Obstructive Pulmonary Disease (COPD). The EASE (Exhale Airway Stents for Emphysema) Trial focuses on airway bypass, an investigational technique without surgery to create new pathways to release trapped air from within diseased lung tissue, thereby helping patients with advanced widespread...

2008-09-25 00:00:02

By The Associated Press CHICAGO (AP) - Inhaler drugs used by millions of people with emphysema and bronchitis might slightly raise the risk for heart attacks and even death, a study suggests.The results aren't conclusive, and inhalers provide significant relief for these patients struggling to breathe. But the study authors urged doctors to closely monitor patients who use the inhalers.Most affected patients have both emphysema and chronic bronchitis. The condition's formal name, chronic...

2008-09-24 09:00:49

Switzerland-based Kuros Biosurgery has granted US-based Aeris Therapeutics an exclusive license in the field of lung volume reduction to certain patent rights Kuros exclusively licensed from the American Red Cross that cover the delivery of certain drugs in a fibrin sealant. In return for the license, Kuros will receive upfronts, milestones and royalties on the sale of Aeris's lead product, the AeriSeal biologic lung volume reduction (BLVR) system, a novel investigational emphysema...

8c7cf2a1621fca3e0f1c414e4df345a71
2008-09-24 07:55:00

Millions of people could be at risk for heart attacks thanks to inhaler drugs used for emphysema and bronchitis, according to a new study. The results aren't conclusive; but they do maintain inhalers provide significant relief for these patients struggling to breathe. However, the study authors told doctors to closely monitor patients who use the inhalers. Many affected patients suffer from emphysema and chronic bronchitis. The condition's formal name, chronic obstructive pulmonary...

2008-09-23 03:00:09

Kuros Biosurgery AG and Aeris Therapeutics, Inc., both privately held biotech companies, announced today that Kuros has granted Aeris an exclusive license in the field of lung volume reduction to certain patent rights Kuros exclusively licensed from the American Red Cross that cover the delivery of certain drugs in a fibrin sealant. In return for the license, Kuros will receive upfronts, milestones and royalties on the sale of Aeris' lead product, the AeriSeal(TM) Biologic Lung Volume...

2008-09-16 09:00:52

Volunteers are being recruited for the research study of a new investigational procedure that could help relieve shortness of breath and other symptoms for people with severe emphysema. Called airway bypass, this minimally invasive procedure creates new openings in the airway wall connecting the damaged lung tissue to the natural airway. These pathways are supported and kept open by Exhale(R) Drug-Eluting Stents. The goal is to give air that is trapped in the lungs a way to escape,...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related